We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9992:HKEXPop Mart International Group Limited Analysis

Data as of 2026-06-10 - not real-time

HK$172.90

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Pop Mart is trading at HK$172.9, well below its DCF‑derived fair value of roughly HK$257, implying an upside of about 25% while its forward PE of ~11.5 suggests cheapness relative to earnings growth. Revenue has surged by over 170% YoY and the company enjoys robust gross (72%) and operating (48%) margins, underscoring a strong growth profile. The stock sits comfortably above its 20‑day (HK$163.6) and 50‑day (HK$159.2) moving averages, and a bullish MACD histogram reinforces short‑term momentum, with volume trending upward. Dividend sustainability looks solid given a modest 8.5% payout ratio and ample cash on hand. However, the consumer‑cyclical nature of the leisure segment, combined with high 30‑day volatility (~40%) and concentrated exposure to China, injects medium‑to‑high risk factors.
Overall, the valuation gap, high profitability, and low dividend burden favor a buying case, while the elevated volatility and regulatory environment in China temper confidence for the longer horizon. Investors should weigh the upside potential against the sector’s discretionary demand risk and maintain vigilance on any policy shifts affecting toy and collectible markets.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and increasing volume
  • Price above 20‑day and 50‑day SMAs
  • Proximity to near‑term resistance with upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Strong profit margins and cash generation
  • Low dividend payout ratio supporting reinvestment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained brand equity in the collectible toy market
  • Exposure to Chinese consumer cycles and regulatory environment
  • Potential convergence of price toward fair value reducing upside

Key Metrics & Analysis

Financial Health

Revenue Growth174.10%
Profit Margin34.42%
P/E Ratio15.6
ROE77.60%
ROA45.32%
Debt/Equity12.63
P/B Ratio9.0
Op. Cash FlowHK$10.9B
Free Cash FlowHK$9.1B

Technical Analysis

TrendNeutral
RSI57.2
SupportHK$144.00
ResistanceHK$186.50
MA 20HK$163.59
MA 50HK$159.21
MA 200HK$215.68
MACDBullish
VolumeIncreasing
Fear & Greed Index85.95

Valuation

Fair ValueHK$256.73
Target PriceHK$215.76
Upside/Downside24.79%
GradeUndervalued
TypeGrowth
Dividend Yield1.62%

Risk Assessment

Beta-0.02
Volatility39.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.